This filing is procedural and contains no new financial information or changes to deal terms. Monitor the exchange offer expiration and subsequent trading volume for MMED as Medtronic's stake is distributed to a broader shareholder base, which could increase free float and liquidity. The key catalyst remains the completion of the separation and MiniMed's standalone operating results.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Sep 14 $21.97entry
- T+1 · 2mo ago +0.18%α +0.64% · $22.01
- T+5 · 8w ago −3.87%α −3.98% · $21.12
- T+20 · 5w ago −14.43%α −16.69% · $18.80
- T+45 · todayOpen
- T+60 · in 21d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
MiniMed filed a 425 communication providing employees with procedural details about Medtronic's exchange offer to divest its remaining ~89.86% stake in MiniMed. This is a routine informational filing for employee participation in the exchange offer, confirming the separation timeline is on track with no changes to deal terms or new financial projections. The filing is a procedural step in the final stage of MiniMed becoming a fully independent company.
Key Facts
- Medtronic currently owns approximately 89.86% of MiniMed's outstanding common stock.
- Medtronic has commenced an exchange offer for its shareholders to swap Medtronic ordinary shares for newly issued MiniMed common stock.
- Upon completion of the exchange offer, Medtronic will no longer hold an equity stake in MiniMed.
- The filing provides employee-specific instructions for tendering shares, including details on vested Medtronic equity awards and ESPP shares.
- MiniMed completed its IPO on March 9, 2026, and the separation was initially announced on May 21, 2025.
Financial Impact
No new financial data or deal value disclosed in this filing. The exchange offer involves Medtronic's remaining ~89.86% stake in MiniMed, valued at approximately $5.66B based on a $6.3B market cap.
Risk Factors
- Exchange offer may not be fully subscribed, leaving Medtronic with a residual stake.
- Post-separation execution risk as MiniMed operates independently without Medtronic support.
- Potential tax implications for Medtronic shareholders participating in the exchange could affect participation rates.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 425 Filing (MMED), Batch item 1 | 0001628280-26-061699 |
| Document: 0001628280-26-061699-index-headers.html | 0001628280-26-061699 |
| Document: 0001628280-26-061699-index.html | 0001628280-26-061699 |
| Document: 0001628280-26-061699.txt | 0001628280-26-061699 |
| 425 Filing (MMED), Batch item 5 | 0001628280-26-061699 |
| Document: 0001628280-26-061699-index-headers.html | 0001628280-26-061699 |
| Document: 0001628280-26-061699-index.html | 0001628280-26-061699 |
| Document: 0001628280-26-061699.txt | 0001628280-26-061699 |
Track record
25 reports on MMED
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today 8-K Mixed 6/10 Entry $18.77 Now $18.65 −0.64% settles Dec 15
- Nov 16, 2026today Press Release Bullish 7/10 Entry $18.81 Now $18.65 −0.86% settles Dec 15
- Nov 6, 202610d ago SC 13G Neutral 4/10 Entry $16.71 Now $18.65 +11.61% settles Dec 7
- Oct 22, 202625d ago SC 13G Neutral 4/10 Entry $18.34 Now $18.65 +1.69% settles Nov 20
- Oct 16, 20264w ago SC 13G/A Neutral 4/10 Entry $17.79 to $18.65 Now $18.65 +4.83% ▲ +4.83% +8.30% vs SPY
- Oct 16, 20264w ago 8-K Neutral 6/10 Entry $17.49 to $17.99 Now $18.65 +6.63% ▲ +2.86% +4.02% vs SPY
- Oct 6, 20265w ago EFFECT Neutral 3/10 Entry $19.64 to $18.85 Now $18.65 −5.04% ▼ −4.02% −0.85% vs SPY
- Oct 1, 20266w ago 3 Neutral 2/10 Entry $19.70 to $18.28 Now $18.65 −5.33% ▼ −7.21% −5.40% vs SPY
- Sep 14, 20269w ago 425 Neutral 4/10 Entry $21.97 to $18.80 Now $18.65 −15.11% ▼ −14.43% −16.69% vs SPY
- Sep 14, 20269w ago 425 Neutral 4/10 Entry $21.97 to $18.80 Now $18.65 −15.11% ▼ −14.43% −16.69% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers